Article Versions Notes

Lefever DE, Miedel MT, Pei F, DiStefano JK, Debiasio R, Shun TY, Saydmohammed M, Chikina M, Vernetti LA, Soto-Gutierrez A, et al. A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies. Metabolites. 2022; 12(6):528. https://doi.org/10.3390/metabo12060528

Lefever, Daniel E., Mark T. Miedel, Fen Pei, Johanna K. DiStefano, Richard Debiasio, Tong Ying Shun, Manush Saydmohammed, Maria Chikina, Lawrence A. Vernetti, Alejandro Soto-Gutierrez, and et al. 2022. "A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies" Metabolites 12, no. 6: 528. https://doi.org/10.3390/metabo12060528

Lefever, D. E., Miedel, M. T., Pei, F., DiStefano, J. K., Debiasio, R., Shun, T. Y., Saydmohammed, M., Chikina, M., Vernetti, L. A., Soto-Gutierrez, A., Monga, S. P., Bataller, R., Behari, J., Yechoor, V. K., Bahar, I., Gough, A., Stern, A. M., & Taylor, D. L. (2022). A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies. Metabolites, 12(6), 528. https://doi.org/10.3390/metabo12060528